# Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia

> **NCT01047397** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 107 (actual)

## Conditions studied

- Kidney Disease

## Interventions

- **DRUG:** 1278863A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01047397
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2013-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01047397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01047397, "Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01047397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*